207 related articles for article (PubMed ID: 8220876)
21. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Osei SY; Ahima RS; Minkes RK; Weaver JP; Khosla MC; Kadowitz PJ
Eur J Pharmacol; 1993 Mar; 234(1):35-42. PubMed ID: 7682513
[TBL] [Abstract][Full Text] [Related]
22. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
Li Q; Zhang J; Pfaffendorf M; van Zwieten PA
Br J Pharmacol; 1996 Aug; 118(7):1653-8. PubMed ID: 8842428
[TBL] [Abstract][Full Text] [Related]
23. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
26. Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.
Gardiner SM; Compton AM; Bennett T; Kemp PA; Ney U
Br J Pharmacol; 1990 Apr; 99(4):830-4. PubMed ID: 2193690
[TBL] [Abstract][Full Text] [Related]
27. Effect of various angiotensin receptor antagonists on cardiovascular responses to angiotensin II in pithed rats.
Zhang J; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1994 Jul; 24(1):108-13. PubMed ID: 7521474
[TBL] [Abstract][Full Text] [Related]
28. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
29. Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats.
Kemp PA; Gardiner SM; March JE; Bennett T; Rubin PC
Br J Pharmacol; 1994 Jan; 111(1):325-31. PubMed ID: 8012714
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Sigmon DH; Beierwaltes WH
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
[TBL] [Abstract][Full Text] [Related]
31. Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 May; 109(1):222-8. PubMed ID: 7684304
[TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
Symons JD; Stebbins CL
J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
[TBL] [Abstract][Full Text] [Related]
33. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat.
Baylis C
Am J Kidney Dis; 1993 Dec; 22(6):842-50. PubMed ID: 8250031
[TBL] [Abstract][Full Text] [Related]
34. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1990 Nov; 101(3):625-31. PubMed ID: 2076481
[TBL] [Abstract][Full Text] [Related]
35. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
Hajj-Ali AF; Reilly TM; Wong PC
J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.
Li Q; Zhang L; Pfaffendorf M; van Zwieten PA
Br J Pharmacol; 1995 Dec; 116(7):2963-70. PubMed ID: 8680731
[TBL] [Abstract][Full Text] [Related]
37. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of angiotensin II and the influence of angiotensin receptor antagonists in pithed rabbits.
Zhang J; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1995 May; 25(5):724-31. PubMed ID: 7630151
[TBL] [Abstract][Full Text] [Related]
39. Regional haemodynamic effects of noradrenaline injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats: possible mechanisms of action.
Bachelard H; Harland D; Gardiner SM; Kemp PA; Bennett T
Neuroscience; 1992; 47(4):941-57. PubMed ID: 1579218
[TBL] [Abstract][Full Text] [Related]
40. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1990 Nov; 101(3):632-9. PubMed ID: 2127552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
